| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 25, 2025 | Buy(P) | 675K | $0.69 | $466K | 2.0M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-002778) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Prelude Therapeutics Inc
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.